Your browser doesn't support javascript.
loading
[Nonalcoholic Fatty Liver Disease and Weight Loss].
Ping, Fan; Li, Yu Xiu.
Afiliación
  • Ping F; Key Laboratory of Endocrinology of Ministry of Health,Department of Endocrinology,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.
  • Li YX; Key Laboratory of Endocrinology of Ministry of Health,Department of Endocrinology,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 40(5): 597-602, 2018 Oct 30.
Article en Zh | MEDLINE | ID: mdl-30404689
ABSTRACT
Nonalcoholic fatty liver disease(NAFLD)refers to hepatic steatosis without other known causes such as alcohol abuse or hepatic virus infection. NAFLD has become a chronic disease worldwide,and its prevalence is constantly growing. Hepatic insulin resistance caused by obesity results in the deposition of triglycerides in the liver,promoting the occurrence and development of NAFLD. Weight loss is the only safe and effective method for NAFLD. Lifestyle intervention plays a cornerstone role in treating NAFLD;however,most patients can not achieve and maintain the ideal body weight by lifestyle intervention alone. Glucagon-like peptide-1 receptor agonist and metabolic surgery are promising treatments for NAFLD.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: Zh Revista: Zhongguo Yi Xue Ke Xue Yuan Xue Bao Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: Zh Revista: Zhongguo Yi Xue Ke Xue Yuan Xue Bao Año: 2018 Tipo del documento: Article País de afiliación: China
...